Mosaic BRAF Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway Inhibition
Sara Barberan-Martin(Great Ormond Street Hospital), Veronica A. Kinsler(Great Ormond Street Hospital), Nicole Knöpfel(Great Ormond Street Hospital), Alan Pittman(St George's, University of London), Melissa Riachi(University College London), Satyamaanasa Polubothu(Great Ormond Street Hospital), Fanourios Michailidis(Great Ormond Street Hospital), Dale Bryant(Great Ormond Street Hospital), Alicia L. Bruzos(Centre National de la Recherche Scientifique), Gavin Kelly(The Francis Crick Institute), Aimie Sauvadet(Great Ormond Street Hospital), Pablo López Balboa(Great Ormond Street Hospital), Iwei Yeh(University of California, San Francisco), Davide Zecchin(University College London), Neil Bulstrode(Great Ormond Street Hospital), Stuart Horswell(The Francis Crick Institute), Amir Sadri(Great Ormond Street Hospital), Noreen Muwanga-Nanyonjo(Great Ormond Street Hospital)
Cited by 20
Related Papers
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
|Nature Genetics|2020|479
Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis
|Journal of Investigative Dermatology|2016|185
Activating MET kinase rearrangements in melanoma and Spitz tumours
|Nature Communications|2015|161
Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi
|Nature Communications|2017|137